The in-vivo study of pain in neuromyelitis optica Autor Tackley, G

Magnetic resonance imaging in neuromyelitis optica. Autor Tackley, G, Kuker, W, Palace, J

Pain in patients with transverse myelitis and its relationship to aquaporin 4 antibody status Autor Kong, Y, Okoruwa, H, Revis, J, Tackley, G, Leite, M, Lee, M, Tracey, I, Palace, J

Risk factors for immunosuppression-associated infections in aquaporin-4 antibody mediated neuromyelitis optica spectrum disorders Autor Cheng, F, George, J, Rocha, J, Tackley, G, Revis, J, Waters, P, Elston, J, Palace, J, Jones, N, Leite, M

Isolated new onset 'atypical' optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up. Autor Piccolo, L, Woodhall, M, Tackley, G, Juryńczyk, M, Kong, Y, Domingos, J, Gore, R, Vincent, A, Waters, P, Leite, M, Palace, J

Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis Autor Jurynczyk, M, Geraldes, R, Probert, F, Woodhall, M, Waters, P, Tackley, G, De Luca, G, Chandratre, S, Leite, M, Vincent, A, Palace, J

Neuromyelitis optica relapses: race and rate, immunosuppression and impairment Autor Tackley, G, O'Brien, F, Rocha, J, Woodhall, M, Waters, P, Chandratre, S, Halfpenny, C, Hemingway, C, Wassmer, E, Wasiewski, W, Leite, M, Palace, J

Chronic neuropathic pain severity is determined by lesion level in aquaporin 4-antibody-positive myelitis Autor Tackley, G, Vecchio, D, Hamid, S, Jurynczyk, M, Kong, Y, Gore, R, Mutch, K, Woodhall, M, Waters, P, Vincent, A, Leite, M, Tracey, I, Jacob, A, Palace, J

An In-vivo 1H-MRS short-echo time technique at 7T: Quantification of metabolites in chronic multiple sclerosis and neuromyelitis optica brain lesions and normal appearing brain tis... Autor Tackley, G, Kong, Y, Minne, R, Messina, S, Winkler, A, Cavey, A, Everett, R, DeLuca, GC, Weir, A, Craner, M, Tracey, I, Palace, J, Stagg, CJ, Emir, U

MOG cell-based assay detects non-MS patients with inflammatory neurologic disease Autor Waters, P, Woodhall, M, O'Connor, K, Reindl, M, Lang, B, Sato, D, Juryńczyk, M, Tackley, G, Rocha, J, Takahashi, T, Misu, T, Nakashima, I, Palace, J, Fujihara, K, Leite, M, Vincent, A

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease. Autor Jurynczyk, M, Probert, F, Yeo, T, Tackley, G, Claridge, T, Cavey, A, Woodhall, M, Arora, S, Winkler, T, Schiffer, E, Vincent, A, DeLuca, G, Sibson, N, Leite, M, Waters, P, Anthony, D, Palace, J

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease Autor Jurynczyk, M, Probert, F, Yeo, T, Tackley, G, Claridge, T, Cavey, A, Woodhall, M, Arora, S, Winkler, T, Schiffer, E, Vincent, A, DeLuca, G, Sibson, N, Leite, M, Waters, P, Anthony, D, Palace, J

Clinical presentation and prognosis in MOG-antibody disease: a UK study Autor Jurynczyk, M, Messina, S, Woodhall, M, Raza, N, Everett, R, Roca-Fernandez, A, Tackley, G, Hamid, S, Sheard, A, Reynolds, G, Chandratre, S, Hemmingway, C, Jacob, A, Vincent, A, Leite, M, Waters, P, Palace, J

Disease course and disability outcomes in MOG-antibody disease in the UK Autor Jurynczyk, M, Messina, S, Woodhall, M, Raza, N, Everett, R, Roca-Fernandez, A, Tackley, G, Hamid, S, Sheard, A, Reynolds, G, Chandratre, S, Hemingway, C, Jacob, A, Vincent, A, Leite, M, Waters, P, Palace, J

Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease Autor Juryńczyk, M, Tackley, G, Kong, Y, Geraldes, R, Matthews, L, Woodhall, M, Waters, P, Kuker, W, Craner, M, Weir, A, DeLuca, G, Kremer, S, Leite, M, Vincent, A, Jacob, A, de Sèze, J, Palace, J